Home
/
Treatment
/
6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride

6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride

	6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride
Trade Name
Orphan Indication	Pulmonary Arterial Hypertension
USA Market Approval	USA
USA Designation Date	2016-11-09 00:00:00
Sponsor	Reviva Pharmaceuticals, Inc.;3900 Freedom Circle, Suite 101;Santa Clara, California, 95054

Related Access Program

Pfizer – Pulmonary Arterial Hypertension (PAH) Pfizer – Pulmonary Arterial Hypertension Bayer – Pulmonary arterial hypertension